Justin Moran

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies

John F. DiJoseph, Douglas Armellino, Erwin R. Boghaert et al. · Blood · 2003 · 354 citations · Full text

Antitumor Efficacy of a Combination of CMC-544 (Inotuzumab Ozogamicin), a CD22-Targeted Cytotoxic Immunoconjugate of Calicheamicin, and Rituximab against Non-Hodgkin's B-Cell Lymphoma

John F. DiJoseph, Maureen Dougher, Lyka B. Kalyandrug et al. · Clinical Cancer Research · 2006 · 140 citations · Full text

Optimization of urinary FDG excretion during PET imaging.

Justin Moran, H B Lee, M. Donald Blaufox · PubMed · 1999 · 72 citations

Determination of pharmacokinetic values of calicheamicin-antibody conjugates in mice by plasmon resonance analysis of small (5 μl) blood samples

Erwin R. Boghaert, Kiran Khandke, Latha Sridharan et al. · Cancer Chemotherapy and Pharmacology · 2007 · 63 citations

Blood Samples, Calicheamicin-antibody Conjugates, Pharmaceutical Science +11

Synthesis of the Protein Cutting Reagent Iron (<i>S</i>)-1-(<i>p</i>-Bromoacetamidobenzyl)ethylenediaminetetraacetate and Conjugation to Cysteine Side Chains

Douglas P. Greiner, Reiko Miyake, Justin Moran et al. · Bioconjugate Chemistry · 1997 · 62 citations